Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
Alfie was an AI-powered clinical decision support platform for obesity and metabolic health management that analyzed patient medical history to recommend evidence-based treatment strategies. The company has been acquired by knownwell and is no longer operating independently.
2 investors
Aligned Bio develops a customizable nanowire sensing platform for single-molecule detection, supporting optical, electrochemical, and electrical sensors. It is building a nanowire-based nucleic acid sequencing platform for next-generation DNA sequencing and molecular biomarker identification, and licenses its patented technology to partners.
2 investors
Alixia develops therapeutics targeting tumor ecosystems to address cancer drug resistance and age-related diseases. The company integrates biology, biophysics, and computational chemistry to design compounds that disrupt metabolic and inflammatory triggers in multiple cell types within the tumor microenvironment.
2 investors
Allevi, part of 3D Systems, makes desktop 3D bioprinters and bioinks used by academic and industry research labs to design and engineer 3D tissues. Its tools support work in regenerative medicine, drug testing, and disease research.
2 investors
ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases. The platform shifts treatment from symptom management to early intervention in at-risk populations.
2 investors
Aloe Therapeutics develops AIM-001, a localized cell-based immunotherapy implanted at tumor sites during surgery to activate the immune system and improve response to checkpoint immunotherapy in patients with advanced solid tumors.
2 investors
Alpha TAU Medical is a clinical-stage oncology company developing Alpha DaRT, an intratumoral alpha-emitting radiotherapeutic that places radium-224 sources inside solid tumors to destroy cancer cells from within. Its tumor-agnostic approach targets multiple solid tumor types, including superficial and deep-seated, metastatic, and inoperable tumors, and is being evaluated as a stand-alone therapy and in combination with systemic agents.
2 investors
Alpha-9 is a clinical-stage radiopharmaceutical company developing a portfolio of targeted molecules to treat cancer cells with precision. It operates in the oncology and precision medicine space.
2 investors
Altasciences is a contract research organization providing biopharmaceutical companies with preclinical safety testing, clinical pharmacology trials, bioanalysis, and manufacturing and analytical services to accelerate early phase drug development.
2 investors
Altavo develops non-invasive silent speech technology using RF sensing and artificial intelligence to help patients who have lost their voice regain natural-sounding speech. The company focuses initially on laryngectomy patients and operates as a medical device startup in Germany.
2 investors
Amferia develops peptide-based medical devices that use antimicrobial peptides to kill bacteria, mimicking the human immune system without toxic effects. The company holds patent protection across Europe, the U.S., and China.
2 investors
Amgen develops therapies based on biotechnology and scientific research aimed at treating patients and improving or saving lives. It operates in the biopharmaceutical industry, moving discoveries from the laboratory through clinical development to market.
2 investors
Amissa Health quantifies symptoms through wearable data and biometric collection to improve clinical care and research, with a focus on early detection of Alzheimer's and digital biomarkers for perimenopause in women. The company serves healthcare institutions, researchers, and patients seeking personalized treatment guidance.
2 investors
Amparo develops a prosthetic fitting system using a pre-assembled, fully remoldable thermoplastic socket that clinicians can fit anywhere in 1-2 hours without specialist machinery, along with the Motio wearable service that collects activity data for lower-limb prosthetic users. It serves orthotics and prosthetics (O&P) clinics and insurance companies to support amputee rehabilitation.
2 investors
AmplifiDx develops point-of-care molecular diagnostic tests and its DX 100 platform for family, women's, and sexual health, targeting infectious disease detection for healthcare professionals and patients. The multiplex platform can detect up to 10 analytes with rapid results and minimal hands-on time.
2 investors
Amplifier Health provides a Voice Intelligence API that extracts over 1,000 acoustic biomarkers from a single voice sample to enable non-invasive health screening and turn any microphone into a clinical diagnostic tool. It serves healthcare and research partners for voice-based condition detection.
2 investors
AMRA Medical provides MRI-based body composition analytics that generate fat and muscle biomarkers for clinical trials and clinical decision-making. It serves researchers and clinicians in drug development and metabolic and musculoskeletal health through services such as AMRA Researcher and the AMRA Profiler 4 medical device.
2 investors
AMS develops next-generation nuclear medicine technologies for Japan's market, including PET diagnostics and radiotherapeutics for precision oncology, alongside a proprietary bedside filtration system for safe radioactive waste management in hospitals.
2 investors
Anaconda Biomed develops neurovascular medical devices, including the ANA funnel-based aspiration catheter, for endovascular treatment of acute ischemic stroke from large vessel occlusion, such as mechanical thrombectomy. Its self-expanding, single-use catheter provides temporary vascular flow restriction and clot collection for neurointervention procedures.
2 investors
Ananya Health develops a portable, battery-powered cryoablation platform for treating pre-cancerous cervical lesions at the point of care in any clinic setting. The medical device targets expanding access to cervical cancer prevention in resource-limited settings by eliminating reliance on costly cryogen gas supply chains.
2 investors
Anatomica manufactures and distributes orthopedic and spinal implants, instruments, and endoprosthetic components for trauma surgery, spine surgery, and orthopedics in Russia. The company operates as an official distributor for international manufacturers and produces its own line of medical devices under the Anatomica brand.
2 investors
Anchora Medical develops the Su2ura Approximation Device, a single-use, 5mm automatic suturing device for endoscopic surgery that places interrupted or running stitches in soft tissue using tiny stainless steel T-tag anchors. The device is intended for surgeons performing minimally invasive procedures and is currently an investigational device not yet available for sale.
2 investors
Angiex develops Nuclear-Delivered Antibody-Drug Conjugate (ND-ADC) therapies for solid cancers, using a platform that delivers chemotherapeutic payloads to the nucleus of tumor cells and tumor blood vessel endothelial cells. Its lead asset, AGX101, is a TM4SF1-directed ADC in Phase 1 clinical development for advanced solid tumors.
2 investors
Angiodroid is a medical technology company providing diagnostic and interventional devices and support services for use in operating rooms and clinical procedures. The company serves hospitals and medical professionals with innovative technologies and offers custom solutions.
2 investors